Sarah Boyce - Jun 24, 2024 Form 3 Insider Report for Contineum Therapeutics, Inc. (CTNM)

Role
Director
Signature
/s/ Peter Slover, Attorney-in-Fact
Stock symbol
CTNM
Transactions as of
Jun 24, 2024
Transactions value $
$0
Form type
3
Date filed
6/24/2024, 04:20 PM
Previous filing
Jun 21, 2024
Next filing
Jul 11, 2024

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney